Novel application of azidothymidine in treating leukaemia

A technology for zidovudine and leukemia, which is applied in the directions of medical preparations containing active ingredients, antiviral agents, organic active ingredients, etc., can solve the problems that have never been seen before.

Inactive Publication Date: 2009-10-21
王意忠 +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But the report that azidothymidine (AZT) is used i

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel application of azidothymidine in treating leukaemia
  • Novel application of azidothymidine in treating leukaemia
  • Novel application of azidothymidine in treating leukaemia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0091] Embodiment 1: tablet

[0092] Azidothymidine is taken, added with conventional auxiliary materials, and prepared into tablets according to a conventional process for treating leukemia.

Embodiment 2

[0093] Embodiment 2: capsules

[0094] Azidothymidine is taken, added with conventional auxiliary materials, and prepared into capsules according to a conventional process, and used for inhibiting the growth of leukemia cells.

Embodiment 3

[0095] Embodiment 3: injection

[0096] Azidothymidine was taken, added with conventional excipients, and prepared into an injection according to a conventional process, which was used to inhibit the growth of human leukemia cell Jukat and mouse leukemia cell L615.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses novel application of azidothymidine in treating leukaemia. Pharmacodynamic experiments show that the azidothymidine has functions of inhibiting the growth of human leukaemia cells Jukat and murine leukemia cells L615, can inhibit the infiltrations of mouse peripheral blood, marrow and liver and spleen organizations, remarkably prolong the life cycle of a leukaemia mouse, and effectively reduce the leucovirus load of a Friend mouse spleen, and has significant effect on treating acute erythroleukemia induced by Friend mouse leucovirus.

Description

field of invention [0001] The invention relates to a new use of zidovudine, and the feature of the invention relates to a new use of zidovudine for treating leukemia. Background technique [0002] Leukemia is a malignant disease of hematopoietic tissue, also known as "blood cancer". It is characterized by the unlimited proliferation of a large number of leukemia cells in the bone marrow and other hematopoietic tissues, and enters the peripheral blood, while the production of normal blood cells is significantly inhibited. Leukemia is a malignant tumor of the hematopoietic system and one of the most common malignant tumors in my country. According to the retrospective survey, the incidence rate of leukemia in various regions occupies the sixth place among all kinds of tumors, and the disease ranks first among malignant diseases among young people. [0003] Azidothymidine (AZT) is a nucleoside reverse transcriptase inhibitor, which has been widely used in the world to treat A...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7072A61P35/02A61P31/12
Inventor 王意忠崔晓兰
Owner 王意忠
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap